8-K
filed July 7, 2026, 9:13 AM ET
ticker OLPX
CIK 0001868726
M&A
confidence high
sentiment neutral
materiality 1.00
Olaplex completes acquisition by Henkel subsidiary for $2.06/share, ~$1.4B equity value
OLAPLEX HOLDINGS, INC.
- Merger closed July 7, 2026; shareholders receive $2.06 per share in cash.
- Total equity value ~$1.4B; funded from Henkel cash on hand.
- Repaid $357.6M credit facility; all outstanding debt obligations satisfied.
- Common stock delisted from Nasdaq; registration to be terminated via Form 25 and Form 15.
- Board replaced: new directors include Amanda Baldwin (CEO), John Duffy, Melisa Gill, Martijn de Regt.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Amanda Baldwin departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Martha Morfitt departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Duffy was appointed as Director at OLAPLEX HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Pamela Edwards departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Emily White departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Deirdre Findlay departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John P. Bilbrey departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Martijn de Regt was appointed as Director at OLAPLEX HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Tricia Glynn departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Melisa Gill was appointed as Director at OLAPLEX HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christine Dagousset departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Amanda Baldwin was appointed as Director at OLAPLEX HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jerome Griffith departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael White departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
David Mussafer departed as Director at OLAPLEX HOLDINGS, INC..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.